Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This phase II trial studies how well simvastatin works in preventing liver cancer in patients with liver cirrhosis. Simvastatin may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
Epistemonikos ID: b6152efd447c71e91822db6a6c56ea185c1305fb
First added on: May 20, 2024